Sirolimus as Primary Therapy for the Treatment of Chronic Graft Versus Host Disease

Clinical trial NCT00186667 · COMPLETED

Trial details

NCT number: NCT00186667
Sponsor: Stanford University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Graft vs Host Disease Blood and Marrow Transplant (BMT)

Start date: 1999-01-01
Primary completion: 2000-01-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.